198 related articles for article (PubMed ID: 29897998)
1. Synergistic anti-tumor effects of liraglutide with metformin on pancreatic cancer cells.
Lu R; Yang J; Wei R; Ke J; Tian Q; Yu F; Liu J; Zhang J; Hong T
PLoS One; 2018; 13(6):e0198938. PubMed ID: 29897998
[TBL] [Abstract][Full Text] [Related]
2. Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Endocrine; 2018 Feb; 59(2):383-394. PubMed ID: 29285650
[TBL] [Abstract][Full Text] [Related]
3. Effect of metformin on cell proliferation, apoptosis, migration and invasion in A172 glioma cells and its mechanisms.
Xiong ZS; Gong SF; Si W; Jiang T; Li QL; Wang TJ; Wang WJ; Wu RY; Jiang K
Mol Med Rep; 2019 Aug; 20(2):887-894. PubMed ID: 31173255
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of metformin with liraglutide against endothelial dysfunction through GLP-1 receptor and PKA signalling pathway.
Ke J; Liu Y; Yang J; Lu R; Tian Q; Hou W; Wang G; Wei R; Hong T
Sci Rep; 2017 Feb; 7():41085. PubMed ID: 28145471
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo anti-melanoma action of metformin.
Janjetovic K; Harhaji-Trajkovic L; Misirkic-Marjanovic M; Vucicevic L; Stevanovic D; Zogovic N; Sumarac-Dumanovic M; Micic D; Trajkovic V
Eur J Pharmacol; 2011 Oct; 668(3):373-82. PubMed ID: 21806981
[TBL] [Abstract][Full Text] [Related]
6. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
[TBL] [Abstract][Full Text] [Related]
7. Synergistic anti-tumor effects of Liraglutide, a glucagon-like peptide-1 receptor agonist, along with Docetaxel on LNCaP prostate cancer cell line.
Eftekhari S; Montazeri H; Tarighi P
Eur J Pharmacol; 2020 Jul; 878():173102. PubMed ID: 32283060
[TBL] [Abstract][Full Text] [Related]
8. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
9. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
Li C; Liu VW; Chan DW; Yao KM; Ngan HY
Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
[TBL] [Abstract][Full Text] [Related]
10. Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived Xenografts.
Lipner MB; Marayati R; Deng Y; Wang X; Raftery L; O'Neil BH; Yeh JJ
PLoS One; 2016; 11(1):e0147113. PubMed ID: 26760500
[TBL] [Abstract][Full Text] [Related]
11. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
Rocha GZ; Dias MM; Ropelle ER; Osório-Costa F; Rossato FA; Vercesi AE; Saad MJ; Carvalheira JB
Clin Cancer Res; 2011 Jun; 17(12):3993-4005. PubMed ID: 21543517
[TBL] [Abstract][Full Text] [Related]
12. Metformin potentiates anti-tumor effect of resveratrol on pancreatic cancer by down-regulation of VEGF-B signaling pathway.
Zhu M; Zhang Q; Wang X; Kang L; Yang Y; Liu Y; Yang L; Li J; Yang L; Liu J; Li Y; Zu L; Shen Y; Qi Z
Oncotarget; 2016 Dec; 7(51):84190-84200. PubMed ID: 27705937
[TBL] [Abstract][Full Text] [Related]
13. Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway.
Zhao H; Wang L; Wei R; Xiu D; Tao M; Ke J; Liu Y; Yang J; Hong T
Diabetes Obes Metab; 2014 Sep; 16(9):850-60. PubMed ID: 24641303
[TBL] [Abstract][Full Text] [Related]
14. Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells.
Karnevi E; Said K; Andersson R; Rosendahl AH
BMC Cancer; 2013 May; 13():235. PubMed ID: 23663483
[TBL] [Abstract][Full Text] [Related]
15. GLP-1 receptor agonist impairs keratinocytes inflammatory signals by activating AMPK.
Yang J; Wang Z; Zhang X
Exp Mol Pathol; 2019 Apr; 107():124-128. PubMed ID: 30776356
[TBL] [Abstract][Full Text] [Related]
16. Liraglutide suppresses the metastasis of PANC-1 co-cultured with pancreatic stellate cells through modulating intracellular calcium content.
Zhao H; Jiang X; Duan L; Yang L; Wang W; Ren Z
Endocr J; 2019 Dec; 66(12):1053-1062. PubMed ID: 31474673
[TBL] [Abstract][Full Text] [Related]
17. [Lily polysaccharide 1 enhances the effect of metformin on proliferation and apoptosis of human breast carcinoma cells].
Hou J; Li F; Li X; Mei Q; Mi M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):780-3. PubMed ID: 27371846
[TBL] [Abstract][Full Text] [Related]
18. Pitavastatin and metformin synergistically activate apoptosis and autophagy in pancreatic cancer cells.
Chen YH; Huang YC; Yang SF; Yen HH; Tsai HD; Hsieh MC; Hsiao YH
Environ Toxicol; 2021 Aug; 36(8):1491-1503. PubMed ID: 33886150
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL
BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471
[TBL] [Abstract][Full Text] [Related]
20. Metformin induces apoptosis of pancreatic cancer cells.
Wang LW; Li ZS; Zou DW; Jin ZD; Gao J; Xu GM
World J Gastroenterol; 2008 Dec; 14(47):7192-8. PubMed ID: 19084933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
